MedPath

To compare the advantage and disadvantage of using bupivacaine 0.5% heavy, isobaric levo-bupivacaine 0.5% and hyperbaric ropivacaine 0.75% in spinal anaesthesia during brachytherapy procedure

Phase 4
Completed
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2023/07/054588
Lead Sponsor
AIIMS NEW DELHI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Patients undergoing interventional brachytherapy procedures under sole spinal anaesthesia.

Exclusion Criteria

patient refusal, allergic to study drugs, contraindication for neuraxial anasthesia, emergency surgeries.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of sensory and motor blocksTimepoint: baseline (before any intervention), and intraoperatively every 2 min till adequate surgical anaesthesia achieved after IT drug administration, followed by every 10 mins after completion of surgery
Secondary Outcome Measures
NameTimeMethod
Onset of sensory and motor block, VAS score, MAP and HRTimepoint: same as primary outcome
© Copyright 2025. All Rights Reserved by MedPath